Machine Learning and Systems Biology Approaches to Characterize Dosage-Based Gene Dependencies in Cancer Cells.

Gene dependencies Machine learning

Journal

Journal of bioinformatics and systems biology : Open access
ISSN: 2688-5107
Titre abrégé: J Bioinform Syst Biol
Pays: United States
ID NLM: 101776626

Informations de publication

Date de publication:
2021
Historique:
entrez: 12 4 2021
pubmed: 13 4 2021
medline: 13 4 2021
Statut: ppublish

Résumé

Mapping of cancer survivability factors allows for the identification of novel biological insights for drug targeting. Using genomic editing techniques, gene dependencies can be extracted in a high-throughput and quantitative manner. Dependencies have been predicted using machine learning techniques on -omics data, but the biological consequences of dependency predictor pairs has not been explored. In this work we devised a framework to explore gene dependency using an ensemble of machine learning methods, and our learned models captured meaningful biological information beyond just gene dependency prediction. We show that dosage-based dependent predictors (DDPs) primarily belonged to transcriptional regulation ontologies. We also found that anti-sense RNAs and long- noncoding RNA transcripts display DDPs. Network analyses revealed that SOX10, HLA-J, and ZEB2 act as a triad of network hubs in the dependent-predictor network. Collectively, we demonstrate the powerful combination of machine learning and systems biology approach can illuminate new insights in understanding gene dependency and guide novel targeting avenues.

Identifiants

pubmed: 33842927
pmc: PMC8031731
mid: NIHMS1678407

Types de publication

Journal Article

Langues

eng

Pagination

13-32

Subventions

Organisme : NCI NIH HHS
ID : P01 CA229100
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG061796
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG056318
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA208517
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA136393
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM072474
Pays : United States

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare that they have no competing interests.

Références

Clin Dev Immunol. 2010;2010:150591
pubmed: 20981248
Nucleic Acids Res. 2017 Jul 3;45(W1):W130-W137
pubmed: 28472511
JCO Clin Cancer Inform. 2020 Apr;4:357-366
pubmed: 32330068
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361
pubmed: 27899662
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Cell. 2017 Jul 27;170(3):564-576.e16
pubmed: 28753430
Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22020-22029
pubmed: 31548386
Nat Rev Nephrol. 2015 Feb;11(2):102-12
pubmed: 25536396
J Invest Dermatol. 2014 Aug;134(8):2212-2220
pubmed: 24608986
Nat Rev Genet. 2017 Oct;18(10):613-623
pubmed: 28649135
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Genome Biol. 2001;2(10):RESEARCH0042
pubmed: 11597334
J Am Soc Nephrol. 2016 Feb;27(2):345-53
pubmed: 26319241
Nucleic Acids Res. 2016 Jun 2;44(10):e100
pubmed: 26975659
Cell Biosci. 2020 Nov 18;10(1):131
pubmed: 33292489
Bioinformatics. 2017 May 1;33(9):1362-1369
pubmed: 28082455
Am J Surg Pathol. 2015 Jun;39(6):826-35
pubmed: 25724000
Front Cell Dev Biol. 2019 Jul 05;7:86
pubmed: 31334229
Nat Commun. 2018 Nov 2;9(1):4610
pubmed: 30389920
Nucleic Acids Res. 2019 Aug 22;47(14):e82
pubmed: 31114928
Nat Genet. 2003 Jan;33(1):19-20
pubmed: 12447372
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Commun. 2019 Aug 20;10(1):3739
pubmed: 31431624
Nat Rev Genet. 2018 Jan;19(1):51-62
pubmed: 29082913
Sci Adv. 2020 Sep 11;6(37):
pubmed: 32917699
J Immunol. 2004 Oct 1;173(7):4561-7
pubmed: 15383589
Nat Rev Genet. 2020 Nov;21(11):671-682
pubmed: 32561862
PLoS One. 2018 Jan 9;13(1):e0190834
pubmed: 29315345
J Hematol Oncol. 2019 Jun 7;12(1):55
pubmed: 31174564
Curr Biol. 2012 Jan 24;22(2):R43-4
pubmed: 22280902
Nature. 2015 Dec 3;528(7580):84-7
pubmed: 26570998
Sci Rep. 2017 Aug 1;7(1):6993
pubmed: 28765560

Auteurs

Kevin Meng-Lin (K)

Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.

Choong Yong Ung (CY)

Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.

Taylor M Weiskittel (TM)

Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.

Alex Chen (A)

Information Systems and Robotics at Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.

Cheng Zhang (C)

Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.

Cristina Correia (C)

Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.

Hu Li (H)

Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.

Classifications MeSH